Correlation Between Biofil Chemicals and Kalpataru Projects

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Kalpataru Projects at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Kalpataru Projects into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Kalpataru Projects International, you can compare the effects of market volatilities on Biofil Chemicals and Kalpataru Projects and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Kalpataru Projects. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Kalpataru Projects.

Diversification Opportunities for Biofil Chemicals and Kalpataru Projects

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biofil and Kalpataru is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Kalpataru Projects Internation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalpataru Projects and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Kalpataru Projects. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalpataru Projects has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Kalpataru Projects go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Kalpataru Projects

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 1.09 times less return on investment than Kalpataru Projects. But when comparing it to its historical volatility, Biofil Chemicals Pharmaceuticals is 1.3 times less risky than Kalpataru Projects. It trades about 0.24 of its potential returns per unit of risk. Kalpataru Projects International is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  119,685  in Kalpataru Projects International on September 19, 2024 and sell it today you would earn a total of  11,750  from holding Kalpataru Projects International or generate 9.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Biofil Chemicals Pharmaceutica  vs.  Kalpataru Projects Internation

 Performance 
       Timeline  
Biofil Chemicals Pha 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Kalpataru Projects 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalpataru Projects International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Kalpataru Projects is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Biofil Chemicals and Kalpataru Projects Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofil Chemicals and Kalpataru Projects

The main advantage of trading using opposite Biofil Chemicals and Kalpataru Projects positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Kalpataru Projects can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalpataru Projects will offset losses from the drop in Kalpataru Projects' long position.
The idea behind Biofil Chemicals Pharmaceuticals and Kalpataru Projects International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm